Chinese Clinical Oncology

• 论著 • Previous Articles     Next Articles

Expressions of EpCAM and Ki-67 in primary lesion and metastatic lymph nodes of triple-negative breast cancer and their clinical significance

LI Jinmei, ZHANG Jinku, ZHOU Bingjuan, CHEN Xue, MA Qiushuang, SUN Jirui, ZHANG Bingxin

  

  1. Department of Pathology, First Central Hospital of Baoding, Baoding 071000, China
  • Received:2014-04-30 Revised:2014-06-30 Online:2014-09-30 Published:2014-09-30
  • Contact: ZHANG Jinku

Abstract:

Objective To investigate the expressions of epithelial cell adhesion molecule(EpCAM) and Ki-67 in primary lesion and metastatic lymph nodes of triple-negetive breast cancer(TNBC) and their clinical significance. Methods The expressions of EpCAM and Ki-67 were examined by SP immunohistochemical stain(IHC) in 81 cases of TNBC, 43 cases of metastatic lymph nodes and 20 cases of normal breast tissues. Results The overexpression rates of EpCAM and Ki-67 were 74.1% and 61.7%,respectively. Moreover, the overexpression of EpCAM and Ki-67 in TNBC was significantly higher than that in normal breast tissues(P<0.05). The overexpression of EpCAM was correlated with differentiation grade and lymph node metastasis of TNBC(P<0.05). On the other hand, the high expression of Ki-67 was correlated with differentiation grade, lymph node metastasis and pTNM staging of TNBC(P<0.05). The overexpression of EpCAM in metastatic lymph nodes was as high as in primary lesion of TNBC, but the high expression of Ki-67 in lymph node metastasis was higher than that in primary lesion(P<0.05). Conclusion EpCAM and Ki-67 are expressed highly both in in primary lesion and metastatic lymph nodes of TNBC. The overexpression of EpCAM and Ki-67 can be closely related with the carcinogenesis and progression of TNBC.

No related articles found!
Viewed
Full text
156
HTML PDF
Just accepted Online first Issue Just accepted Online first Issue
0 0 0 0 0 156

  From Others local
  Times 3 153
  Rate 2% 98%

Abstract
132
Just accepted Online first Issue
0 0 132
  From Others
  Times 132
  Rate 100%

Cited

Web of Science  Crossref   ScienceDirect  Search for Citations in Google Scholar >>
 
This page requires you have already subscribed to WoS.
  Shared   
  Discussed   
No Suggested Reading articles found!